Sibai B., Romero R., Klebanoff M. A., Rice M. M., Caritis S., Lindheimer M. D., Van Dorsten J. P., Landon M., Miodovnik M., Dombrowski M., Meis P.. Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. American Journal of Obstetrics and Gynecology 2009; 200 (6):.
Siebner H. R., Bergmann T. O., Bestmann S., Massimini M., Johansen-Berg H., Mochizuki H., Bohning D. E., Boorman E. D., Groppa S., Miniussi C., Pascual-Leone A., Huber R., Taylor P. C. J., Ilmoniemi R. J., De Gennaro L., Strafella A. P., Kahkonen S., Kloppel S., Frisoni G. B., George M. S., Hallett M., Brandt S. A., Rushworth M. F., Ziemann U., Rothwell J. C., Ward N., Cohen L. G., Baudewig J., Paus T., Ugawa Y., Rossini P. M.. Consensus paper: Combining transcranial stimulation with neuroimaging. Brain Stimulation 2009; 2 (2):58-80.
Sievert A. N., Shackelford A. G., McCall M. M.. Trends and emerging technologies in extracorporeal life support: results of the 2006 ECLS survey. The Journal of extra-corporeal technology 2009; 41 (2):73-8.
Silvestri G. A.. The Mounting Evidence for Endobronchial Ultrasound. Chest 2009; 136 (2):327-328.
Silvestri G. A., Alberg A. J., Ravenel J.. The changing epidemiology of lung cancer with a focus on screening. BMJ 2009; 339 ():b3053.
Silvestri G. A., Vincent B. D., Wahidi M. M., Robinette E., Hansbrough J. R., Downie G. H.. A Phase 3, Randomized, Double-Blind Study To Assess the Efficacy and Safety of Fospropofol Disodium Injection for Moderate Sedation in Patients Undergoing Flexible Bronchoscopy. Chest 2009; 135 (1):41-47.
Simon R. D. B., Sturdivant J. L., Leman R. B., Wharton J. M., Gold M. R.. The Effect of Dofetilide on Ventricular Defibrillation Thresholds. Pace-Pacing and Clinical Electrophysiology 2009; 32 (1):24-28.
Simon R. D., Sturdivant J. L., Leman R. B., Wharton J. M., Gold M. R.. The effect of dofetilide on ventricular defibrillation thresholds. Pacing and clinical electrophysiology : PACE 2009; 32 (1):24-8.
Simpson K. N., Dietz B., Rahim S., Rajagopalan R.. Cost Effectiveness of Switching to Second Line Therapy with Lopinavir/Ritonavir (Lpv/R) in Kenya. Value in Health 2009; 12 (3):A116-A116.
Simpson K. N., Rajagopalan R., Dietz B.. Cost-effectiveness analysis of lopinavir/ritonavir and atazanavir plus ritonavir regimens in the CASTLE study. Advances in therapy 2009; 26 (2):185-193.
Simpson K. N., Rajagopalan R., Dietz B.. Cost-effectiveness analysis of lopinavir/ritonavir and atazanavir+ritonavir regimens in the CASTLE study. Advances in Therapy 2009; 26 (2):185-93.
Simpson K. N., Strassburger A., Jones W. J., Dietz B., Rajagopalan R.. Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV. Pharmacoeconomics 2009; 27 (2):159-165.
Simpson K. N., Welch M. J., Kozel F. A., Demitrack M. A., Nahas Z.. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis. Advances in therapy 2009; 26 (3):346-368.
Singareddy R., Ubde T. W.. Nocturnal sleep panic and depression: Relationship to subjective sleep in panic disorder. Journal of Affective Disorders 2009; 112 (1-3):262-266.
Singh A. K., Riederer B., Krabbenhoft A., Rausch B., Bonhagen J., Dringenberg U., Engelhardt R., Schweinfest C. W., Soleimani M., Manns M. P., Seidler U.. Gemetic deletion of NHE3, Slc26a6, Slc26a3 and CFTR helps unravel the different pathways for duodenal HCO3- AND H+ secretion in vivo. Journal of Physiological Sciences 2009; 59 (Suppl.):297-297.
Singh I., Singh A. K., Contreras M. A.. Peroxisomal Dysfunction in Inflammatory Childhood White Matter Disorders: An Unexpected Contributor to Neuropathology. Journal of Child Neurology 2009; 24 (9):1147-1157.
Singh J., Khan M., Singh I.. Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy. Journal of Lipid Research 2009; 50 (1):135-147.
Sisson E., Kuhn C.. Pharmacist roles in the management of patients with type 2 diabetes. Journal of the American Pharmacists Association 2009; 49 ():S41-S45.
Skinner H. J., Thompson A. R., Dubon S. A., Medina M. T., Nicholas J. S., Edwards J. C., Holden K. R.. Convulsive Status Epilepticus in Honduran Adults. Epilepsia 2009; 50 ():188-189.
Slate E. H., Bandyopadhyay D.. An investigation of the MC-SIMEX method with application to measurement error in periodontal outcomes. Statistics in Medicine 2009; 28 (28):3523-3538.
Slaughter J., Annibale D., Suresh G.. False-negative results of pre-discharge neonatal bilirubin screening to predict severe hyperbilirubinemia: a need for caution. European Journal of Pediatrics 2009; 168 (12):1461-1466.
Slomiany M. G., Dai L., Bomar P. A., Knackstedt T. J., Kranc D. A., Tolliver L., Maria B. L., Toole B. P.. Abrogating Drug Resistance in Malignant Peripheral Nerve Sheath Tumors by Disrupting Hyaluronan-CD44 Interactions with Small Hyaluronan Oligosaccharides. Cancer Research 2009; 69 (12):4992-4998.
Slomiany M. G., Dai L., Tolliver L. B., Grass G. D., Zeng Y. P., Toole B. P.. Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides. Clinical Cancer Research 2009; 15 (24):7593-7601.
Slomiany M. G., Grass G. D., Robertson A. D., Yang X. Y., Maria B. L., Beeson C., Toole B. P.. Hyaluronan, CD44, and Emmprin Regulate Lactate Efflux and Membrane Localization of Monocarboxylate Transporters in Human Breast Carcinoma Cells. Cancer research 2009; 69 (4):1293-1301.
Slomiany Mark G., Dai Lu, Bomar Paul A., Knackstedt Thomas J., Kranc D. Alex, Tolliver Lauren, Maria Bernard L., Toole Bryan P.. Abrogating Drug Resistance in Malignant Peripheral Nerve Sheath Tumors by Disrupting Hyaluronan-CD44 Interactions with Small Hyaluronan Oligosaccharides. Cancer Research 2009; 69 (12):4992-4998.
Slomiany Mark G., Toole Bryan P.. Hyaluronan-CD44 interactions and chemoresistance in cancer cells. In: Stern Robert, editor. Hyaluronan in Cancer Biology. New York: Academic Press, 2009. p. 19-35.
Smith Jr. Robert S., Gao Lin, Bledsoe Grant, Chao Lee, Chao Julie. Intermedin is a new angiogenic growth factor. American Journal of Physiology 2009; 297 (3, Pt. 2):H1040-H1047.
Smith C. D., Maines L. W., Zhuang Y., Green C. L., Keller S. N., Beljanski V., Knaak C., Wang W.. Preclinical development of orally available sphingosine kinase inhibitors. Journal of Clinical Oncology 2009; 27 (15): e14615.
Smith G. M., Ferguson P. L., Wagner J. L., Wannamaker B. B.. Self-Efficacy and Depression Assessment. Epilepsia 2009; 50 ():291-291.
Smith G., Ferguson P. L., Saunders L. L., Wagner J. L., Wannamaker B. B.. Psychosocial factors associated with stigma in adults with epilepsy. Epilepsy and Behavior 2009; 16 (3):484-490.
Smith J. A., Zhang R., Varma A. K., Das A., Ray S. K., Banik N. L.. Estrogen partially down-regulates PTEN to prevent apoptosis in VSC4.1 motoneurons following exposure to IFN-gamma. Brain Research 2009; 1301 ():163-170.
Smith J. P., Book S. W.. Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment. Addictive Behaviors 2009; 35 (1):42-45.
Smith J. P., Tonigan J. S.. Relative Engagement and Benefit from Alcoholics Anonymous (Aa) among Alcoholics Living Alone. Alcoholism-Clinical and Experimental Research 2009; 33 (6):46A-46A.
Smith J. P., Tran G. Q., Randall C.. Gender Differences in Young Adults' Help-Seeking Attitudes and Intentions for Alcohol Problems. Alcoholism-Clinical and Experimental Research 2009; 33 (6):128A-128A.
Smith Joshua A., Zhang Ran, Varma Abhay K., Das Arabinda, Ray Swapan K., Banik Naren L.. Estrogen partially down-regulates PTEN to prevent apoptosis in VSC4.1 motoneurons following exposure to IFN-γ. Brain Research 2009; 1301 (Complete):163-170.
Smith R. J., Aston-Jones G.. Inactivating the activated: identifying functions of specific neural networks. Nature Neuroscience 2009; 12 (8):965-6.
Smith R. J., Aston-Jones G.. Inactivating the activated: identifying functions of specific neural networks.[comment]. Nature Neuroscience 2009; 12 (8):965-6.
Smith R. J., See R. E., Aston-Jones G.. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. European Journal of Neuroscience 2009; 30 (3):493-503.
Smothers C. T., Jin C., Woodward J. J.. Effect of N-Terminal Domains of Nr1 and Nr2 Subunits on Ethanol Inhibition of Recombinant Nmda Receptors. Alcoholism-Clinical and Experimental Research 2009; 33 (6):148A-148A.
Smothers C. Thetford, Woodward John J.. Expression of glycine-activated diheteromeric NR1/NR3 receptors in human embryonic kidney 293 cells is NR1 splice variant-dependent. Journal of Pharmacology and Experimental Therapeutics 2009; 331 (3):975-984.
Snider A. J., Kawamori T., Bradshaw S. G., Orr K. A., Gilkeson G. S., Hannun Y. A., Obeid L. M.. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB Journal 2009; 23 (1):143-152.
Soder B. L., Propst J. T., Brooks T. M., Goodwin R. L., Friedman H. I., Yost M. J., Gourdie R. G.. The Connexin43 Carboxyl-Terminal Peptide ACT1 Modulates the Biological Response to Silicone Implants. Plastic and reconstructive surgery 2009; 123 (5):1440-1451.
Solomon K. D., de Castro L. E. F., Sandoval H. P., Biber J. M., Groat B., Neff K. D., Ying M. S., French J. W., Donnenfeld E. D., Lindstrom R. L.. LASIK World Literature Review Quality of Life and Patient Satisfaction. Ophthalmology 2009; 116 (4):691-701.
Solomons J. T. G.. The structural basis of cooperativity in a novel pyruvate kinase from Pyrobaculum aerophilum. MUSC Dissertation 2009; ():119 pp.
Song P. H., Groos S., Riederer B., Feng Z., Krabbenhoft A., Smolka A., Seidler U.. KCNQ1 is the luminal K+ recycling channel during stimulation of gastric acid secretion. Journal of Physiology 2009; 587 (15):3955-3965.
Sotka E. E., McCarty A., Monroe E. A., Oakman N., Van Dolah F. M.. Benthic Herbivores are not Deterred by Brevetoxins Produced by the Red Tide Dinoflagellate Karenia brevis. Journal of Chemical Ecology 2009; 35 (7):851-859.
Sotka E. E., McCarty A., Monroe E. A., Oakman N., Van Dolah F. M.. Benthic herbivores are not deterred by brevetoxins produced by the red tide dinoflagellate Karenia brevis. Journal of Chemical Ecology 2009; 35 (7):851-9.
Soundararajan S., Wang L., Sridharan V., Chen W. W., Courtenay-Luck N., Jones D., Spicer E. K., Fernandes D. J.. Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells. Molecular Pharmacology 2009; 76 (5):984-991.
Soundararajan Sridharan, Wang Li, Sridharan Vijayalakshmi, Chen Weiwei, Courtenay-Luck Nigel, Jones David, Spicer Eleanor K., Fernandes Daniel J.. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Molecular Pharmacology 2009; 76 (5):984-991.
Spaeth E. L., Watson K., Toole B., Klopp A., Andreeff M., Marini F.. Tumor-Specific Migration of MSC Mediated by CD44 and Accessory Chemokine Receptors CXCR1 and CXCR2. Molecular Therapy 2009; 17 ():S160-S160.
